IBM Aspera Faspex authorization flaw is under active exploitation
CISA reports active exploitation of CVE-2026-123218, a critical authorization flaw in IBM Aspera Faspex 5.0.0 through 5.0.19, fixed in 5.0.19 PL1.
The U.S. Cybersecurity and Infrastructure Security Agency (CISA) reports active exploitation of an authorization flaw in IBM Aspera Faspex 5.0.0 through 5.0.19. The flaw is tracked as CVE-2026-123218, a Common Vulnerabilities and Exposures (CVE) identifier. CISA added the flaw to its Known Exploited Vulnerabilities (KEV) catalog on November 9, 2026.
What is affected
The affected product is IBM Aspera Faspex, and the affected versions are 5.0.0 through 5.0.19. The vulnerability is classified as CWE (Common Weakness Enumeration) 863, incorrect authorization. An authenticated user can craft a specific message to bypass authorization and gain full administrative privileges.
Why it matters
The CVSS (Common Vulnerability Scoring System) base score is 9.8, critical. The fixed release is IBM Aspera Faspex 5.0.19 PL1, which fixes CVE-2026-123218. The KEV entry sets a CISA remediation due date of November 12, 2026.
What to do
For deployments in the affected range, upgrade to IBM Aspera Faspex 5.0.19 PL1. CISA requires applying mitigations in accordance with vendor instructions.
Sources
Related reading
3 postsDiscussion
Spotted an error? Send corrections to [email protected] .